Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1612 1654 1717 3774
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18834637 | THERAGNOSTIC FOLATE CONJUGATES | Non-Final OA | MERCK PATENT GMBH |
| 18294646 | AGENTS, COMPOSITIONS, AND METHODS FOR CANCER DETECTION | Non-Final OA | The Johns Hopkins University |
| 18553092 | HETEROBIVALENT AND HOMOBIVALENT AGENTS TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA AND/OR PROSTATE-SPECIFIC MEMBRANE ANTIGEN | Non-Final OA | The Johns Hopkins University |
| 18572536 | 3-Iodopropyl-1,2,3-Triazol-1-yl, 3-Bromopropyl-1,2,3-Triazol-1-yl, and Derivatives for Uses in Labeling | Non-Final OA | Emory University |
| 18834373 | PROBE FOR NUCLEAR MEDICAL TESTING | Non-Final OA | The University of Tokyo |
| 18721744 | TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18385428 | BIOCOMPATIBLE RADIONUCLIDE-CONTAINING COMPOSITIONS AND METHODS OF USE | Non-Final OA | UT-Battelle, LLC |
| 18293488 | RADIOLABELED COMPOUND AND USE THEREOF | Non-Final OA | OSAKA UNIVERSITY |
| 18546131 | EXTRACELLULAR VESICLE LINKED TO A BIOLOGICALLY ACTIVE MOLECULE VIA AN OPTIMIZED LINKER AND AN ANCHORING MOIETY | Non-Final OA | LONZA SALES AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy